Results 251 to 260 of about 167,795 (308)

Combined modality therapy for pancreatic cancer

Seminars in Oncology, 2003
In spite of the high mortality in pancreatic cancer, significant progress is being made. This review discusses multimodality therapy for patients with pancreatic cancer. According to several phase II trials and Gastrointestinal Tumor Study Group results, improvements in locoregional control and survival may be achieved when chemotherapy is added to ...
James Y, Tsai, David A, Iannitti, Howard, Safran   +2 more
openaire   +2 more sources

Combined modality therapy for gynecologic cancer

Current Opinion in Oncology, 1995
The use of combined modality therapy in the primary management of gynecologic cancer continues to be explored. Although early ovarian cancer is treated with postoperative adjuvant treatment, the data to support its value is lacking. In advanced disease, paclitaxel has emerged as the most optimal treatment after maximal cytoreduction.
I, Ackerman, G M, Thomas
openaire   +2 more sources

Combined modality therapy for esophageal cancer

Current Oncology Reports, 1999
Whereas many patients with esophageal carcinoma present with what appears to be localized disease, cure rates with surgical resection alone remain low. Although surgical resection, where feasible, affords patients the best chance of cure, the primary tumor has often invaded local tissues or structures, and occult micrometastases often exist at the time
Z, Gamliel, M J, Krasna
openaire   +2 more sources

Combined modality therapy of esophageal carcinoma

Cancer, 1981
One hundred ten patients with epidermoid carcinoma of the esophagus were treated at the Memorial Sloan-Kettering Cancer Center (MSKCC) with combined modality techniques involving preoperative irradiation (RT) and surgery, and with preoperative chemotherapy (CT), surgery, and irradiation.
D P, Kelsen, R, Ahuja, S, Hopfan, M S, Bains, C, Kosloff, N, Martini, P, McCormack, R B, Golbey   +7 more
openaire   +2 more sources

Combined Modality Therapy of Gastric Cancer

Surgical Oncology Clinics of North America, 1997
Most patients with adenocarcinoma of the stomach continue to present with advanced stages of disease. Although cure is not possible without complete resection, most patients will go on to recur and die of their disease. Despite the efforts of the last 3 to 4 decades, little progress has been made in improving disease specific survival.
M S, Karpeh, D P, Kelsen
openaire   +2 more sources

Combined Modality Therapy

2014
Radiation therapy can be modified by increasing the effectiveness of radiation on tumors (radiosensitizers), protecting normal tissues (radioprotectors), increasing oxygen concentration, or by using systemic therapy drugs. Radio-protectors are described by their dose reduction factor (DRF) while radio-sensitizers are described by their enhancement ...
David S. Chang, Foster D. Lasley, Indra J. Das, Marc S. Mendonca, Joseph R. Dynlacht   +4 more
openaire   +1 more source

Combined Modality Therapy for Rectal Cancer

The Cancer Journal, 2016
The primary therapy for any potentially curative rectal cancer is surgery. For locally advanced tumors (i.e., T3-4 and/or node positive), the very high rate of local and distant recurrences has necessitated a standard adjuvant regimen of preoperative chemoradiation and postoperative chemotherapy.
Sagar A, Patel, David P, Ryan, Theodore S, Hong   +2 more
openaire   +2 more sources

Combined Modality Therapy in the Elderly Population

Current Treatment Options in Oncology, 2009
The incidence of cancer among older patients continues to rise. The use of combined modality therapy has improved survival in a variety of malignancies, including rectal, head and neck, and lung cancer; however, the addition of chemotherapy increases substantially the toxicities of treatment.
Lilie L, Lin, Stephen M, Hahn
openaire   +2 more sources

Combined Modality Therapy for Rectal Cancer

The Cancer Journal, 2010
The standard adjuvant treatment for cT3 and/or N+ rectal cancer is preoperative chemoradiation. However, there are many controversies regarding this approach. These include the role of short course radiation, whether postoperative adjuvant chemotherapy necessary for all patients and whether the type of surgery after chemoradiation should be based on ...
Minsky, Bd, Roedel, C, Valentini, Vincenzo   +2 more
openaire   +3 more sources

Combined Modality Therapy of Esophageal Cancer

Journal of the National Comprehensive Cancer Network, 2008
Esophageal cancer is a deadly disease. Only one third of patients with localized disease experience long-term survival. Over the past 20 years, investigators have evaluated neoadjuvant strategies to improve the outcomes of surgical management. Chemotherapy and radiation have been evaluated individually and in combination for preoperative management of ...
Rosalyn A, Juergens, Arlene, Forastiere
openaire   +2 more sources